Fifty Undergraduate Students at Twenty-three Universities to Benefit from AstraZeneca Bursary Programme
Boost for Chemistry Education in United Kingdom
AstraZeneca announced today a bursary
programme worth at least £200,000 for students working toward a first degree in
chemistry. Financial support, in
the amount of £1,000 each year, will be provided to 50 students starting their
studies in October 2002 at universities across the UK, including the University
is crucial that we continue to stress the importance of science education in the
UK, especially as more-and-more students choose careers in disciplines outside
the physical sciences,” said Sir Harry Kroto, Nobel Laureate and Professor of
Chemistry at the University of Sussex. “We
are very grateful to AstraZeneca for supporting science education in a way that
encourages students at university level to carry on with their studies in
chemistry, and we are hopeful that universities across the UK will reap the
benefits from these newly motivated chemistry students.”
is one of the world’s leading pharmaceutical companies with two major
laboratories in the UK, at Loughborough, Leicestershire, and at Alderley Park,
Cheshire. Worldwide, the Company
spends more than £7 million each working day on research and development of new
medicines for areas of serious, unmet medical need.
AstraZeneca already invests heavily in the advancement of science
education within the UK through the £20 million AstraZeneca Science Teaching
Trust fund, as well as numerous local school sponsorships.
need highly skilled and motivated chemists if we are to remain successful in the
years ahead,” said Dame Bridget Ogilvie, Non-Executive Director of AstraZeneca,
Trustee of the National Endowment for Science, Technology and the Arts, and
Chair of the AstraZeneca Science Teaching Trust.
“With this awards scheme, we aim to encourage young people to continue
studying chemistry and, ultimately, to pursue a career in the field as well.”
will be 50 awards of £1,000 a year for the length of a student’s course (3-4
years). Students opting to obtain work experience as part of their study will be
offered the opportunity to work at AstraZeneca, where they will be paid a
salary, which will exceed £1,000, in place of the bursary for that time period.
The bursaries will be available to students at 23 universities with
strong chemistry programmes where AstraZeneca has existing links: Bath, Bristol,
Cambridge, Durham, Edinburgh, Glasgow, Leeds, Leicester, Liverpool, Imperial
College London, Loughborough, Manchester, Nottingham, Oxford, Reading,
Sheffield, Southampton, Strathclyde, Sussex, UMIST, University College London,
Warwick and York.
qualify for an award, students must have an A or B grade at Chemistry A-level
(or higher equivalent), be registered on a BSc/MChem chemistry course (or
equivalent) and maintain a reasonable level of degree course performance (2:1 or
above). Upon entrance to university
in October, candidates should inquire with their Chemistry Department for
details of the selection procedure. Students
will compete within their university’s department for available bursaries by
completing an application and providing a CV. This
process will not begin until October 2002.
candidates will have the opportunity to visit one of AstraZeneca’s research
sites in the UK, as well as be given preferential consideration for work
placement opportunities within AstraZeneca, upon graduation.
is a major international healthcare business engaged in the research,
development, manufacture and marketing of prescription pharmaceuticals and the
supply of healthcare services. It is one of the top five pharmaceutical
companies in the world with healthcare sales of over $16.4 billion and leading
positions in sales of gastrointestinal, oncology, anaesthesia (including pain
management), cardiovascular, central nervous system (CNS) and respiratory
to editors: For more information contact Emily Denney +44 (0) 20 7304 5034 or
Gill Hilsdon +44 (0) 15 0964 4038
This document has been approved by the head of department or section.